Search
Search Results
##search.searchResults.foundPlural##
-
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
1045PDF: 601HTML: 2230Cover Letter: 229 -
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
3040PDF: 1159HTML: 133 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1512PDF: 876HTML: 3144 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3401PDF: 1101HTML: 2441 -
THE IMPACT OF HUMAN PLATELET ANTIGEN ALLELE ON ANTIPLATELET ANTIBODIES AND CRYOGLOBULINS IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA AND HEPATITIS C VIRUS-ASSOCIATED IMMUNE THROMBOCYTOPENIA Human platelet antigen and immune thrombocytopenia
1226PDF: 1051Suppl. Files: 492HTML: 367 -
MALARIA AND HIV IN ADULTS: When The Parasite runs into The Virus
2805PDF: 1080HTML: 2395 -
Lymphomatoid Granulomatosis of Central Nervous System and Lung Driven by Epstein Barr Virus Proliferation: Successful Treatment with Rituximab
1719PDF: 961HTML: 3197Figure 5: 191Figure 4: 191Figure 3: 225Figure 1: 206Figure 2: 204 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
4619PDF: 1549HTML: 8546 -
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1728PDF: 875HTML: 1281Figure 1: 211Figure 2: 223Figure 3: 223 -
NOVEL MUTATIONS IN THE NON-STRUCTURE PROTEIN 2 OF SARS-CoV-2 Sequence analysis NSP2 of SARS-CoV-2
1106PDF: 521HTML: 162 -
Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome
1945PDF: 897HTML: 1646 -
Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
3457PDF: 625HTML: 731 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1549PDF: 1390HTML: 120 -
Acute Cytomegalovirus infection as a cause of venous thromboembolism
1661PDF: 894HTML: 1084Picture 1: 206 -
Cardiac toxicity associated with HCV direct antiviral agents Heart in HCV DAAs therapy
1686PDF: 1033HTML: 237 -
HIV INFECTION, ANTIRETROVIRAL THERAPY AND CARDIOVASCULAR RISK
1956PDF: 845HTML: 3692 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
775PDF: 493HTML: 6287 -
Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines
4454PDF: 1261HTML: 2421Figure 1: 217 -
A HEALTH RELATED QUALITY OF LIFE AND PSYCHOPATHOLOGICAL SYMPTOMS IN PEOPLE WITH HEMOPHILIA, BLOODBORNE CO-INFECTIONS AND COMORBIDITIES: AN ITALIAN MULTICENTER OBSERVATIONAL STUDY PSYCHOLOGICAL DINAMICS OF A GROUP OF ITALIAN HEMOPHILIACS WITH AND WITHOUT (CO)INFECTIONS AND COMORBIDITIES: A MULTICENTER STUDY
1650PDF: 1299HTML: 536 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4737PDF: 2022HTML: 18185 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
8348PDF: 4493HTML: 7578 -
Seroprevalence of transfusion-transmissible infections among family replacement donors and voluntary non-remunerated blood donors during the COVID-19 pandemic in sub Saharan Africa family replacement donors and voluntary non-remunerated blood donors in transfusion transmissible infections
1722PDF: 1371HTML: 177 -
Status Epilepticus Due to Severe HHV-6 Encephalitis in an Allogeneic Stem Cell Transplant Recipient
1251PDF: 881HTML: 2197Figue 1: 205







